Allianz Asset Management
ASTH icon

Allianz Asset Management’s Astrana Health ASTH Stock Holding History

Allianz Asset Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-32,600
Closed -$1.01M – 2336
2025
Q1 		$1.01M Buy
32,600
+8,000
+33% +$267K ﹤0.01% 1679
2024
Q4 		$776K Buy
24,600
+10,300
+72% +$489K ﹤0.01% 1723
2024
Q3 		$829K Buy
14,300
+3,500
+32% +$172K ﹤0.01% 1696
2024
Q2 		$438K Buy
10,800
+3,400
+46% +$135K ﹤0.01% 1873
2024
Q1 		$311K Sell
7,400
-15,500
-68% -$605K ﹤0.01% 1740
2023
Q4 		$877K Buy
22,900
+5,662
+33% +$189K ﹤0.01% 1648
2023
Q3 		$532K Buy
17,238
+10,338
+150% +$357K ﹤0.01% 1901
2023
Q2 		$218K Sell
6,900
-8,600
-55% -$295K ﹤0.01% 1882
2023
Q1 		$565K Sell
15,500
-19,500
-56% -$683K ﹤0.01% 1874
2022
Q4 		$1.04M Buy
+35,000
New +$1.13M ﹤0.01% 1512

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Allianz Asset Management's ASTH Position: Q2 2025 in Review

Allianz Asset Management sold out of Astrana Health (ASTH) in Q2 2025, closing a stake of 32,600 shares — an estimated $1.01M sold.

Allianz Asset Management first reported a position in ASTH in Q4 2022 and held it in 10 quarters. The position peaked at $1.04M in Q4 2022. 162 funds tracked by Wall St. Rank hold ASTH as of Q2 2025.

  • Allianz Asset Management reported no remaining Astrana Health position as of Q2 2025 after selling out during the quarter.
  • Allianz Asset Management sold 32,600 Astrana Health shares in Q2 2025, an estimated $1.01M.
  • Allianz Asset Management first reported a position in Astrana Health in Q4 2022 and held it in 10 quarters.
  • Allianz Asset Management's Astrana Health position peaked at $1.04M in Q4 2022.
  • 162 funds tracked by Wall St. Rank held Astrana Health as of Q2 2025.

Based on Allianz Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.